Genetics and epigenetics in perioperative medicine

Current Opinion in Critical Care

Volumn 18, Issue 5, 2012, Pages 548-554

  Bain, Chris R ^a   Shaw, Andrew D ^b  

^a ALFRED HOSPITAL   (Australia)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epigenome wide association study; Epigenomics; Genome wide association study; Perioperative genomics; Pharmacogenetics

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CODEINE; CYCLIC AMP; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DNA METHYLTRANSFERASE; GENOMIC DNA; GLUTAMATE DECARBOXYLASE 65; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; METOPROLOL; MORPHINE; MU OPIATE RECEPTOR; OPIATE; OPIATE RECEPTOR; OXYCODONE; PREGNANE X RECEPTOR; PROTEIN; TRICHOSTATIN A; VORINOSTAT;

BREAST FEEDING; CARDIOVASCULAR DISEASE; CHRONIC PAIN; CORONARY ARTERY BYPASS GRAFT; CPG ISLAND; DNA METHYLATION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PROCEDURES; GENETIC TEST; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEART SURGERY; HISTONE MODIFICATION; HUMAN; HUMAN GENETICS; HYPERALGESIA; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; LIVER METABOLISM; LOGISTIC REGRESSION ANALYSIS; MORTALITY; NEUROPATHIC PAIN; NONHUMAN; OUTCOMES RESEARCH; PAIN; PERIOPERATIVE MEDICINE; PEROPERATIVE CARE; PHARMACODYNAMICS; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; POSTOPERATIVE PAIN; PROMOTER REGION; RECEPTOR GENE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL CORD; SPINAL GANGLION; STROKE; SURGICAL PATIENT; SURVIVAL; TRANSCRIPTION REGULATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TWINS;

EPIGENOMICS; GENE EXPRESSION; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PERIOPERATIVE CARE; PHARMACOGENETICS; RISK FACTORS;

EID: 84866004734     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328357af6d     Document Type: Review

References (42)

1. Janicki PK, Vealey R, Liu J, et al. Genome-wide Association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting. Anesthesiology 2011; 115:54-64.
2. Muehlschlegel JD, Liu KY, Perry TE, et al., for the CABG genomics investigators. Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. Circulation 2010; 122:S60-S65.
3. LeMaire SA, McDonald M-LN, Guo D-C, et al. Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet 2011; 43:996-1000.
4. Shaw A. Exploring the perioptome: the role of genomics in thoracic surgery and anaesthesia. Curr Opin Anaesthesiol 2007; 20:32-36. (Pubitemid 46071980)
5. Shaw A, VandeVen T. Secrets of the perioptome: new tools for a new concept. Curr Opin Crit Care 2010; 16:365-370.
6. Bird A. Perceptions of epigenetics. Nature 2007; 447:396-398. (Pubitemid 46816744)
7. Géranton S. Current opinion in pharmacology: targeting epigenetic mechanisms for pain relief. Curr Opin Pharmacol 2012; 12:25-41.
8. Meaney MJ, Ferguson-Smith AC. Epigenetic regulation of the neural transcriptome: the meaning of the marks. Nat Neurosci 2010; 13:1313-1318.
9. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011; 12:529-541.
10. Kuner R. Central mechanisms of pathological pain. Nat Med 2010; 16:1258-1266.
11. Rakyan VK, Beyan H, Down TA, et al. Identification of type 1 diabetesassociated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011; 7:e1002300.
12. Géranton SM, Morenilla-Palao C, Hunt SP. A role for transcriptional repressor methyl-CpG-binding protein 2 and plasticity-related gene serum-and glucocorticoid-inducible kinase 1 in the induction of inflammatory pain states. J Neurosci 2007; 27:6163-6173. (Pubitemid 46890014)
13. Tochiki K, Cunningham J, Hunt S. The expression of spinal methyl-CpGbinding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states. Mol Pain 2012; 8:14.
14. Bai G, Wei D, Zou S, et al. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Mol Pain 2010; 6:51.
15. Zhang Z, Cai Y-Q, Zou F, et al. Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 2011; 17:1448-1455.
16. Grocott HP, White WD, Morris RW, et al. Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke 2005; 36:1854-1858. (Pubitemid 41266513)
17. Ikram M, Seshadri S, Bis J, et al. Genomewide association studies of stroke. N Engl J Med 2009; 360:1718-1728.
18. Cole JW, Stine OC, Liu X, et al. Rare Variants in ischemic stroke: an Exome Pilot Study. PLoS ONE 2012; 7:e35591.
19. Liangos O, Domhan S, Schwager C, et al. Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation. PLoS ONE 2010; 5:e13658.
20. Martin DS, Khosravi M, Grocott MP, Mythen MG. Concepts in hypoxia reborn. Crit Care 2010; 14:315.
21. Nanduri J, Makarenko V, Reddy VD, et al. Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis. Proc Natl Acad Sci 2012; 109:2515-2520.
22. Landau R, Bollag LA, Kraft JC. Pharmacogenetics and anaesthesia: the value of genetic profiling. Anaesthesia 2012; 67:165-179.
23. Madadi P, Koren G, Cairns J, et al. Safety of codeine during breastfeeding. Can Fam Physician 2007; 53:33-35.
24. Koren G, Cairns J, Chitayat D, et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006; 368: 704. (Pubitemid 44223697)
25. US-FDA Information for healthcare professionals: use of codeine products in nursing mothers -August 2007; http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm124889.htm. [Accessed 15 April 2012]
26. Juurlink DN, Gomes T, Guttmann A, et al. Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: a retrospective cohort study. Clin Toxicol 2012; 50:390-395.
27. Samer C, Daali Y, Wagner M. The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone. Br J Pharmacol 2010; 160:907-918.
28. Samer C, Daali Y, Wagner M. Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety. Br J Pharmacol 2010; 160:919-930.
29. Dannenberg L, Edenberg HJ. Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics 2006; 7:181.
30. Takagi S, Nakajima M, Mohri T, Yokoi T. Posttranscriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 2008; 283:9674-9680.
31. Walter C, Lötsch J. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain 2009; 146:270-275.
32. Angst M, Phillips N, Drover D, Tingle M. Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain (in press). doi:10.1016/j.pain. 2012.02.022.
33. Hwang CK, Kim CS, Kim DK, et al. Up-regulation of the opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells. Mol Pharmacol 2010; 78:58-68.
34. Nielsen DA, Hamon S, Yuferov V, et al. Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum Genet 2010; 127:639-649.
35. Badgett RG, Lawrence VA, Cohn SL. Variations in pharmacology of betablockers may contribute to heterogeneous results in trials of perioperative beta-blockade. Anesthesiology 2010; 113:585-592.
36. Badgett RG, Lawrence VA, Cohn SL. How often should atenolol be dosed for perioperative ß-blockade? Anesthesiology 2011; 115:1140-1141.
37. Nagele P, Liggett SB. Genetic Variation, b-blockers, and perioperative myocardial infarction. Anesthesiology 2011; 115:1316-1327.
38. Homeyer von P, Schwinn DA. Pharmacogenomics of b-adrenergic receptor physiology and response to b-blockade. Anesth Analg 2011; 113:1305-1318.
39. Rau T, Wuttke H, Michels LM, et al. Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study. Clin Pharmacol Ther 2009; 85:269-272.
40. Wallace AW, Au S, Cason BA. Perioperative b-blockade: atenolol is associated with reduced mortality when compared to metoprolol. Anesthesiology 2011; 114:824-836.
41. Frey UH, Adamzik M, Kottenberg-Assenmacher E, et al. A novel functional haplotype in the human GNAS gene alters Galphas expression, responsiveness to beta-adrenoceptor stimulation, and peri-operative cardiac performance. Eur Heart J 2009; 30:1402-1410.
42. Frey UH, Kottenberg E, Kamler M, et al. Genetic interactions in the badrenoceptor/ G-protein signal transduction pathway and survival after coronary artery bypass grafting: a pilot study. Br J Anaesth 2011; 107: 869-878.